HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

CTFA Promotes Drug Harmonization Model For Cosmetics Industry

This article was originally published in The Rose Sheet

Executive Summary

The cosmetics industry should adopt the International Conference on Harmonisation model as part of its global harmonization efforts, Cosmetic, Toiletry and Fragrance Association VP-International Lou Santucci said during a presentation at the Health & Beauty America conference Sept. 27-29 in New York City

You may also be interested in...



CTFA Stresses Importance Of FD&C Act In Congressional Outreach

The Cosmetic, Toiletry and Fragrance Association will work this year to communicate to Congress the value of the FD&C Act in regulating cosmetic safety, according to CTFA President Pam Bailey

CTFA Stresses Importance Of FD&C Act In Congressional Outreach

The Cosmetic, Toiletry and Fragrance Association will work this year to communicate to Congress the value of the FD&C Act in regulating cosmetic safety, according to CTFA President Pam Bailey

REACH Requirements Eased For Certain Chemicals Under Amendment

The European Parliament Environment Committee is recommending an amendment easing registration requirements for chemicals produced in quantities between one and ten tons under the REACH chemicals program. The committee adopted a report with a large number of amendments Oct. 4 by a vote of 40-19, with two abstentions

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

RS013393

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel